Filing Details
- Accession Number:
- 0001209191-14-075849
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-16 16:14:37
- Reporting Period:
- 2014-12-12
- Filing Date:
- 2014-12-16
- Accepted Time:
- 2014-12-16 16:14:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242825 | M Jeffrey Leiden | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-12-12 | 2,500 | $0.00 | 267,694 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2014-12-15 | 13,021 | $113.19 | 254,673 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 15,440 | $114.21 | 239,233 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 6,406 | $115.05 | 232,827 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 3,400 | $116.27 | 229,427 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 8,650 | $117.26 | 220,777 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 2,700 | $118.05 | 218,077 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 200 | $119.00 | 217,877 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-12-15 | 200 | $120.17 | 217,677 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 440 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
- Represents a gift made to a charitable donor-advised fund.
- Open market sales reported on this line occurred at a weighted average price of $113.19 (range $112.66 to $113.65).
- Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $114.21 (range $113.66 to $114.65).
- Open market sales reported on this line occurred at a weighted average price of $115.05 (range $114.69 to $115.68).
- Open market sales reported on this line occurred at a weighted average price of $116.27 (range $115.73 to $116.70).
- Open market sales reported on this line occurred at a weighted average price of $117.26 (range $116.74 to $117.73).
- Open market sales reported on this line occurred at a weighted average price of $118.05 (range $117.74 to $118.64).
Billionaire Hedge Funds
